{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:37Z","timestamp":1790946697057,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["2015-MSCRFI-1662 and 2018-MSCRFD-4246"],"award-info":[{"award-number":["2015-MSCRFI-1662 and 2018-MSCRFD-4246"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children's Gaucher Research Fund","award":["No Grant Number"],"award-info":[{"award-number":["No Grant Number"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Gaucher Disease (GD), which is the most common lysosomal storage disorder, is caused by bi-allelic mutations in GBA1\u2014a gene that encodes the lysosomal hydrolase \u03b2-glucocerebrosidase (GCase). The neuronopathic forms of GD (nGD) are characterized by severe neurological abnormalities that arise during gestation or early in infancy. Using GD-induced pluripotent stem cell (iPSC)-derived neuronal progenitor cells (NPCs), we have previously reported that neuronal cells have neurodevelopmental defects associated with the downregulation of canonical Wnt signaling. In this study, we report that GD NPCs display elevated levels of Dkk1, which is a secreted Wnt antagonist that prevents receptor activation. Dkk1 upregulation in mutant NPCs resulted in an increased degradation of \u03b2-catenin, and there was a concomitant reduction in lysosomal numbers. Consistent with these results, incubation of the mutant NPCs with recombinant Wnt3a (rWnt3a) was able to outcompete the excess Dkk1, increasing \u03b2-catenin levels and rescuing lysosomal numbers. Furthermore, the incubation of WT NPCs with recombinant Dkk1 (rDkk1) phenocopied the mutant phenotype, recapitulating the decrease in \u03b2-catenin levels and lysosomal depletion seen in nGD NPCs. This study provides evidence that downregulation of the Wnt\/\u03b2-catenin pathway in nGD neuronal cells involves the upregulation of Dkk1. As Dkk1 is an extracellular Wnt antagonist, our results suggest that the deleterious effects of Wnt\/\u03b2-catenin downregulation in nGD may be ameliorated by the prevention of Dkk1 binding to the Wnt co-receptor LRP6, pointing to Dkk1 as a potential therapeutic target for GBA1-associated neurodegeneration.<\/jats:p>","DOI":"10.3390\/biom10121630","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T20:09:40Z","timestamp":1607026180000},"page":"1630","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-4141","authenticated-orcid":false,"given":"Manasa P.","family":"Srikanth","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in gaucher\u2019s disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the erad process of the l444p mutant glucocerebrosidase variant","volume":"46","author":"Ron","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5858\/2008-132-851-GDROTL","article-title":"Gaucher disease: Review of the literature","volume":"132","author":"Chen","year":"2008","journal-title":"Arch. Pathol. Lab. Med"},{"key":"ref_4","first-page":"299","article-title":"Gaucher disease: Clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2014.02.011","article-title":"Taliglucerase alfa: An enzyme replacement therapy using plant cell expression technology","volume":"112","author":"Grabowski","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_6","first-page":"273","article-title":"Gaucher disease: Insights from a rare mendelian disorder","volume":"14","author":"Sidransky","year":"2012","journal-title":"Discov. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: Clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"key":"ref_8","first-page":"7","article-title":"Gaucher disease: New expanded classification emphasizing neurological features","volume":"13","author":"Alaei","year":"2019","journal-title":"Iran. J. Child. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15227950500405296","article-title":"Perinatal lethal gaucher disease: A distinct phenotype along the neuronopathic continuum","volume":"24","author":"Eblan","year":"2005","journal-title":"Fetal Pediatr. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of nonneuronopathic gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","article-title":"Neuropathic gaucher disease","volume":"160","author":"Pastores","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Roshan Lal, T., and Sidransky, E. (2017). The spectrum of neurological manifestations associated with gaucher disease. Diseases, 5.","DOI":"10.3390\/diseases5010010"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","article-title":"Management of neuronopathic gaucher disease: Revised recommendations","volume":"32","author":"Vellodi","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-7091-1511-4_20","article-title":"Neuronal forms of gaucher disease","volume":"216","author":"Vitner","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","article-title":"Glucocerebrosidase gene mutations in patients with type 2 gaucher disease","volume":"15","author":"Stone","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/00006450-200008000-00018","article-title":"Glucosylsphingosine accumulation in mice and patients with type 2 gaucher disease begins early in gestation","volume":"48","author":"Orvisky","year":"2000","journal-title":"Pediatr. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of type 2 gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_20","first-page":"2712","article-title":"The contribution of mutant gba to the development of parkinson disease in drosophila","volume":"25","author":"Maor","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","article-title":"Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in parkinson\u2019s patient midbrain neurons","volume":"36","author":"Mazzulli","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and alpha-synuclein aggregation in parkinson\u2019s disease: Diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine promotes alpha-synuclein pathology in mutant gba-associated parkinson\u2019s disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/auto.6.5.12047","article-title":"Impaired autophagosomes and lysosomes in neuronopathic gaucher disease","volume":"6","author":"Sun","year":"2010","journal-title":"Autophagy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic gaucher disease in the mouse: Viable combined selective saposin c deficiency and mutant glucocerebrosidase (v394l) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/hmg\/ddv297","article-title":"Altered tfeb-mediated lysosomal biogenesis in gaucher disease ipsc-derived neuronal cells","volume":"24","author":"Awad","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","article-title":"Gba deficiency promotes snca\/alpha-synuclein accumulation through autophagic inhibition by inactivated ppp2a","volume":"11","author":"Du","year":"2015","journal-title":"Autophagy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"Ipsc-derived neurons from gba1-associated parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Brown, R.A., Voit, A., Srikanth, M.P., Thayer, J.A., Kingsbury, T.J., Jacobson, M.A., Lipinski, M.M., Feldman, R.A., and Awad, O. (2019). Mtor hyperactivity mediates lysosomal dysfunction in gaucher\u2019s disease ipsc-neuronal cells. Dis. Model. Mech., 12.","DOI":"10.1242\/dmm.038596"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"Tfeb links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mtor and tfeb","volume":"31","author":"Settembre","year":"2012","journal-title":"Embo. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.celrep.2012.09.026","article-title":"Presenilin deficiency or lysosomal inhibition enhances wnt signaling through relocalization of gsk3 to the late-endosomal compartment","volume":"2","author":"Dobrowolski","year":"2012","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1137065","article-title":"Wnt induces lrp6 signalosomes and promotes dishevelled-dependent lrp6 phosphorylation","volume":"316","author":"Huang","year":"2007","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2010.11.034","article-title":"Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes","volume":"143","author":"Taelman","year":"2010","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin d1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/emboj.2012.146","article-title":"Three decades of wnts: A personal perspective on how a scientific field developed","volume":"31","author":"Nusse","year":"2012","journal-title":"Embo. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn2755","article-title":"Emerging roles of wnts in the adult nervous system","volume":"11","author":"Inestrosa","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1523\/JNEUROSCI.3248-11.2011","article-title":"Wnt signaling in amygdala-dependent learning and memory","volume":"31","author":"Maguschak","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.cub.2016.07.024","article-title":"Reversal of synapse degeneration by restoring wnt signaling in the adult hippocampus","volume":"26","author":"Marzo","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.conb.2018.06.003","article-title":"Wnt proteins as modulators of synaptic plasticity","volume":"53","author":"McLeod","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1326-3-9","article-title":"The role of wnt signaling in neuronal dysfunction in alzheimer\u2019s disease","volume":"3","author":"Inestrosa","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41598-018-20836-w","article-title":"Impaired wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered drosophila parkinson\u2019s disease model","volume":"8","author":"Stephano","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2012.07.030","article-title":"Inhibition of the canonical wnt pathway by dickkopf-1 contributes to the neurodegeneration in 6-ohda-lesioned rats","volume":"525","author":"Dun","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of dickkopf-1, a negative modulator of the wnt pathway, is associated with neuronal degeneration in alzheimer\u2019s brain","volume":"24","author":"Caricasole","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2010.10.023","article-title":"Reactive astrocytes and wnt\/\u03b2-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinson\u2019s disease","volume":"41","author":"Tirolo","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1038\/sj.onc.1210053","article-title":"Wnts as ligands: Processing, secretion and reception","volume":"25","author":"Mikels","year":"2006","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/dvdy.22019","article-title":"Regulation of wnt\/beta-catenin signaling by protein kinases","volume":"239","author":"Verheyen","year":"2010","journal-title":"Dev. Dyn."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0959-437X(98)80068-3","article-title":"Beta-catenin: A key mediator of wnt signaling","volume":"8","author":"Willert","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35077108","article-title":"Ldl-receptor-related protein 6 is a receptor for dickkopf proteins","volume":"411","author":"Mao","year":"2001","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the dickkopf family of wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lfs.2018.08.019","article-title":"Dickkopf-1: Current knowledge and related diseases","volume":"209","author":"Huang","year":"2018","journal-title":"Life Sci."},{"key":"ref_54","first-page":"419","article-title":"Alzheimer disease","volume":"22","author":"Apostolova","year":"2016","journal-title":"Continuum"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","article-title":"Increased dickkopf-1 expression in transgenic mouse models of neurodegenerative disease","volume":"112","author":"Rosi","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lecourt, S., Mouly, E., Freida, D., Cras, A., Ceccaldi, R., Heraoui, D., Chomienne, C., Marolleau, J.-P., Arnulf, B., and Porcher, R. (2013). A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 gaucher disease patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069293"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced wnt\/beta-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher ipsc-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.5966\/sctm.2014-0213","article-title":"Gaucher disease-induced pluripotent stem cells display decreased erythroid potential and aberrant myelopoiesis","volume":"4","author":"Sgambato","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.stemcr.2017.10.029","article-title":"Altered differentiation potential of gaucher\u2019s disease ipsc neuronal progenitors due to wnt\/beta-catenin downregulation","volume":"9","author":"Awad","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"Gsk-3: Tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2010.12.003","article-title":"Wnt signaling: Multivesicular bodies hold gsk3 captive","volume":"143","author":"Niehrs","year":"2010","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.274142.115","article-title":"Ampk governs lineage specification through tfeb-dependent regulation of lysosomes","volume":"30","author":"Young","year":"2016","journal-title":"Genes. Dev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/34848","article-title":"Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction","volume":"391","author":"Glinka","year":"1998","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2141.2007.06871.x","article-title":"Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of dkk1 correlates with clinical bone involvement at diagnosis","volume":"140","author":"Haaber","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the wnt-signaling antagonist dkk1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2009.10.030","article-title":"Increased dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis","volume":"46","author":"Ko","year":"2010","journal-title":"Bone"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00198-016-3802-5","article-title":"Increased levels of dickkopf-1 are indicative of wnt\/\u03b2-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density","volume":"28","author":"Tsentidis","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1523\/JNEUROSCI.5230-04.2005","article-title":"Induction of dickkopf-1, a negative modulator of the wnt pathway, is required for the development of ischemic neuronal death","volume":"25","author":"Cappuccio","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","article-title":"Identification of modifier genes in a mouse model of gaucher disease","volume":"16","author":"Klein","year":"2016","journal-title":"Cell Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"E5317","DOI":"10.1073\/pnas.1804091115","article-title":"Arginine methylation is required for canonical wnt signaling and endolysosomal trafficking","volume":"115","author":"Albrecht","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1158\/0008-5472.CAN-17-3199","article-title":"The canonical wnt pathway drives macropinocytosis in cancer","volume":"78","author":"Binyamin","year":"2018","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.devcel.2018.02.013","article-title":"Apc inhibits ligand-independent wnt signaling by the clathrin endocytic pathway","volume":"44","author":"Benchabane","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"107973","DOI":"10.1016\/j.celrep.2020.107973","article-title":"Gsk3 inhibits macropinocytosis and lysosomal activity through the wnt destruction complex machinery","volume":"32","author":"Albrecht","year":"2020","journal-title":"Cell Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00701-013-1663-7","article-title":"Enhanced neuroregenerative effects by scaffold for the treatment of a rat spinal cord injury with wnt3a-secreting fibroblasts","volume":"155","author":"Park","year":"2013","journal-title":"Acta. Neurochir."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4103\/1673-5374.158360","article-title":"Neuroprotective effect of rapamycin on spinal cord injury via activation of the wnt\/\u03b2-catenin signaling pathway","volume":"10","author":"Gao","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/neu.2013.3067","article-title":"Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury","volume":"31","author":"Shields","year":"2014","journal-title":"J. Neurotrauma"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/neu.2016.4871","article-title":"Intranasally delivered wnt3a improves functional recovery after traumatic brain injury by modulating autophagic, apoptotic, and regenerative pathways in the mouse brain","volume":"35","author":"Zhang","year":"2018","journal-title":"J. Neurotrauma"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1523\/JNEUROSCI.2352-17.2018","article-title":"Intranasal wnt3a attenuates neuronal apoptosis through frz1\/piwil1a\/foxm1 pathway in mcao rats","volume":"38","author":"Matei","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-dkk1 mab (bhq880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bjh.13056","article-title":"A phase ib multicentre dose-determination study of bhq880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events","volume":"167","author":"Iyer","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"823875","DOI":"10.5402\/2012\/823875","article-title":"Functional characterization of a small-molecule inhibitor of the dkk1-lrp6 interaction","volume":"2012","author":"Iozzi","year":"2012","journal-title":"ISRN Mol. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bioorg.2018.06.018","article-title":"Design and synthesis of gallocyanine inhibitors of dkk1\/lrp6 interactions for treatment of alzheimer\u2019s disease","volume":"80","author":"Thysiadis","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddx442","article-title":"Gaucher disease ipsc-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition","volume":"27","author":"Panicker","year":"2018","journal-title":"Hum. Mol. Genet."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/12\/1630\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:02Z","timestamp":1760179262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/12\/1630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":86,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["biom10121630"],"URL":"https:\/\/doi.org\/10.3390\/biom10121630","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}